 Today, I have the pleasure of speaking with Dr. John Gluckman from Six Wave Innovations. How are you today, Dr. Gluckman? I'm fantastic. Thanks for having me again, Tracy. Dr. Gluckman never has Six Wave been more critical to our market than 2022, 2021, and the COVID virus. Can you tell us how Six Wave is offering a solution to alleviate some of our stress? When this happened, we decided that we could utilize our molecular imprinted polymer technology for detection of these kinds of airborne pathogens, whether they're bacteria or viruses. Over the last year, we have successfully developed a polymer that can detect the COVID virus and all of the variants that we've been exposed to so far at levels that are better than an immunoassay test. We do this with a completely artificial polymer technology, our MIPS, and we've been able to prove that with electronic detection, with fluorescent detection, and with visual detection. We're now at the final end of doing cross-reactivity testing against a battery of 50 different pathogens, and starting next month, we'll be productizing our first products for diagnostic tests for COVID and submitting that for clinical trials in just the next 60 days, roughly. Okay, so your news release you just put out about partnering with TraceSafe. Yeah. Can you talk to us a little bit about that? Yeah, so depending on who you talk to, maybe we're late in the game for COVID. But the news today on COVID has been showing that as we're decreasing masking that that's going to continue to plague us and numbers are going up around the world. One of the interesting things though is that we set out from the very beginning to develop a platform for being able to rapidly develop products for any pathogen. One of the areas that's come to the forefront besides human pathogens is protecting the food chain. There are significant pathogens that happen in agriculture. There's African swine fever, there's M1H1, or avian flu that we've all heard about. And these are highly communicable. And there are really no tests that are deployable in this market. So we can very rapidly, instead of imprinting for COVID, use our platform and imprint for African swine fever and create the same kinds of rapidly deployable surveillance systems, things that can operate by constantly sampling water supplies or waste streams or even being used by the vet as a test that they can take out to the farm, test an animal and right there be able to determine that the animal is sick and what corrective action needs to be taken to quarantine animals. The Canada, for example, exports about 80% of its pork. We're very lucky that we don't have African swine flu here quite yet or fever here quite yet. But when we do, that's going to have a significant impact on exportability. China has had to destroy millions of hogs from this and it's running rampant and being spread by feral pigs and hogs throughout Europe. So these are the kinds of pathogens that have the potential to really impact our food supplies and our economy here in Canada and around the world. And there are no tests. And we're working very fiercely now to configure not just a test from the sensor standpoint, which is our piece, but from a larger information sharing and surveillance platform, which is the piece that TraceSafe is bringing to the table. So question for you, TraceSafe patents, because this sounds very complicated. It does sound complicated. Can you tell us about the patents that you have or the competitive advantage of the TraceSafe technology? So TraceSafe is really a communications technology. It's based in Bluetooth and other kinds of things. So if you think about contact tracing, if you will, you get data. So you have a sensor like ours that says, hey, you have COVID or that this farm has African swine fever. What TraceSafe is going to provide is the ability for us to take that electronic detection and transmit it to a contact tracing system where all that information will be observable, whether that information is observable to the farmer or whether it's observable and managed by the veterinarian or whether it's managed by by regulatory environments. And there are industry associations that even have their own self-reporting tools. And so what TraceSafe brings to the table is the ability for us to get from our sensor to automatically reporting the data to places that it's needed. For more information on TraceSafe or to speak to Dr. John Gluckman, please email the following email or go to this website. Thank you so much, Dr. Gluckman for the update today from Six Wave Innovations. Thank you. My pleasure. And thank you again, TraceSafe.